Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to educate people with bronchiectasis about how to better manage the disease.

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

Analysts have recently evaluated Elanco Animal Health and provided 12-month price targets. The average target is $15.25, ...

Guidelines aimed at increasing transparency about how the regulator will evaluate pharmaceutical pricing, official says ...

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural ...

Galapagos announces leadership transition. European biotechnology company Galapagos completed a significant leadership ...

Weber Shandwick MENAT has launched the second edition of InfluAnswer Arabia, a report informed by the perspectives of cont ...

Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural ...

PRNewswire/ -- (Nasdaq: CTSH) and Aker Solutions, a global leader from Norway in the energy industry, have extended their ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with ...